What Is the BALANCE Model? GLP-1 Coverage Future (2026)
the short answer
The BALANCE Model is a federal program that aims to expand GLP-1 access by negotiating lower prices for state Medicaid programs and, eventually, Medicare Part D. State Medicaid agencies can opt in starting May 2026. The Medicare Part D portion has been delayed indefinitely, so the temporary GLP-1 Bridge was extended through the end of 2027 to fill the gap.
what BALANCE is trying to do
It pairs two things: negotiated, lower GLP-1 prices and required lifestyle support. The goal is to make these medications affordable for Medicaid and Medicare populations while controlling cost to taxpayers, and to learn whether combining medication with lifestyle help produces better long-term results.
the timeline that matters
which drugs qualify
Eligible products act on GLP-1 or related receptor pathways and have shown a meaningful average reduction in body weight in clinical trials. The practical list depends on which manufacturers choose to participate, since the program is voluntary on all sides.
lifestyle support is part of the deal
Under BALANCE, people receiving a GLP-1 for weight management are also offered a lifestyle support program at no cost. The medication is treated as one part of care, not the whole of it.
balance is about access plus support, not medication alone.
what it means for you, and the 2028 question
If your state opts in, Medicaid access may broaden. For Medicare, the Bridge carries weight-loss coverage through 2027, but the path after that is uncertain while the Part D portion is on hold. If you start treatment now, it is worth planning for continuity rather than assuming coverage will simply roll forward.
questions people ask
What is the BALANCE Model?
A federal program that negotiates GLP-1 prices so state Medicaid programs and, eventually, Medicare Part D plans can cover them more affordably, paired with lifestyle support.
When does it start?
State Medicaid agencies can opt in starting May 2026. The Medicare Part D portion has been delayed indefinitely, and the temporary GLP-1 Bridge was extended through the end of 2027 to fill the gap.
Does BALANCE guarantee I will be covered?
No. Participation is voluntary for states, plans, and manufacturers, and eligibility rules still apply. It expands access where the pieces line up, not everywhere.
Which drugs qualify?
Products that act on GLP-1 or related pathways and have been shown to reduce body weight by a meaningful amount in clinical trials. The exact list depends on manufacturer participation.
See if you qualify and get started
_This article is for education and is not medical advice. Coverage rules change often and vary by plan, state, and diagnosis; confirm current details with your plan or at cms.gov before acting. Reviewed by Dr. Linda Moleon, MD. If a GLP-1 might be right for you, talk with a licensed clinician._
Keep reading
What Your Doctor Needs to Document for GLP-1 Approval (2026)
Approval usually comes down to what is in your chart: diagnosis, BMI now and at the start of therapy, related conditions, and treatment history. The checklist to bring to your visit.
GLP-1 Insurance Glossary: 15 Terms to Know (2026)
Insurance has its own vocabulary, and a few terms decide whether your GLP-1 gets covered. The 15 that matter, defined in plain language.
Does Your State Medicaid Cover GLP-1s? How to Check (2026)
Whether your state Medicaid covers a GLP-1 for weight loss comes down to one state policy choice. How to find your state's rule, what is covered regardless, and your options if excluded.
Cash-Pay GLP-1s vs. Insurance in 2026 (incl. TrumpRx)
Self-pay GLP-1 prices have fallen to roughly $150 to $500 a month. When cash beats insurance, when coverage still wins, and what to avoid either way.
Does Medicare Cover Ozempic, Wegovy & Zepbound? (2026)
Standard Part D cannot cover GLP-1s for weight loss alone, but it covers specific drugs for diabetes, heart risk, and sleep apnea. For weight loss, the new $50/month Medicare Bridge is the path.
Will Insurance Cover Your GLP-1 in 2026? Commercial, Medicaid & Medicare
Coverage depends on who insures you and why the medication is prescribed. In 2026 more doors opened than ever, including a new Medicare program that brings certain GLP-1s to about $50 a month.